The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Newcastle Disease Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1).
The global Newcastle Disease Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Newcastle Disease Treatment in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes and Retail Pharmacies, are propelling Newcastle Disease Treatment market. Live Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at % CAGR for the next seven-year period.
The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a significant growth over a forecast period due to the increasing initiatives by government to ensure food security and awareness regarding mass vaccination programs that would create sustainable demand for vaccines for national stockpiles. The Europe has also contributed the moderate shares and registered a healthy growth rate to the Newcastle Disease Treatment market followed by North America. The APAC has become the lucrative market for Newcastle Disease Treatment and anticipated to register significant shares over the forecast period due to the increasing research and development activities and government initiatives to invest in veterinary vaccines for both livestock and companion animals. The Latin America and MEA are at a nascent stage to the Newcastle Disease Treatment market and expected to show a moderate growth over a forecast period owing to improve access to healthcare facilities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Newcastle Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Newcastle Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Newcastle Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Newcastle Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Newcastle Disease Treatment covered in this report include Indovax, Zoetis, Eli Lilly, Merck and Ceva, etc.
The global Newcastle Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Indovax
Zoetis
Eli Lilly
Merck
Ceva
Global Newcastle Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Newcastle Disease Treatment market, Segment by Type:
Live Attenuated Vaccine
Inactivated Vaccine
Conjugated Vaccine
Global Newcastle Disease Treatment market, by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Newcastle Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1).
The global Newcastle Disease Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Newcastle Disease Treatment in various end use industries. The expanding demands from the Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes and Retail Pharmacies, are propelling Newcastle Disease Treatment market. Live Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inactivated Vaccine segment is estimated at % CAGR for the next seven-year period.
The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a significant growth over a forecast period due to the increasing initiatives by government to ensure food security and awareness regarding mass vaccination programs that would create sustainable demand for vaccines for national stockpiles. The Europe has also contributed the moderate shares and registered a healthy growth rate to the Newcastle Disease Treatment market followed by North America. The APAC has become the lucrative market for Newcastle Disease Treatment and anticipated to register significant shares over the forecast period due to the increasing research and development activities and government initiatives to invest in veterinary vaccines for both livestock and companion animals. The Latin America and MEA are at a nascent stage to the Newcastle Disease Treatment market and expected to show a moderate growth over a forecast period owing to improve access to healthcare facilities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Newcastle Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Newcastle Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Newcastle Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Newcastle Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Newcastle Disease Treatment covered in this report include Indovax, Zoetis, Eli Lilly, Merck and Ceva, etc.
The global Newcastle Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Indovax
Zoetis
Eli Lilly
Merck
Ceva
Global Newcastle Disease Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Newcastle Disease Treatment market, Segment by Type:
Live Attenuated Vaccine
Inactivated Vaccine
Conjugated Vaccine
Global Newcastle Disease Treatment market, by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Newcastle Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Newcastle Disease Treatment
1.1 Newcastle Disease Treatment Market Overview
1.1.1 Newcastle Disease Treatment Product Scope
1.1.2 Newcastle Disease Treatment Market Status and Outlook
1.2 Global Newcastle Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Newcastle Disease Treatment Market Size by Region (2018-2029)
1.4 Global Newcastle Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Newcastle Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Newcastle Disease Treatment Market Size (2018-2029)
1.6.1 North America Newcastle Disease Treatment Market Size (2018-2029)
1.6.2 Europe Newcastle Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Newcastle Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Newcastle Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Newcastle Disease Treatment Market Size (2018-2029)
2 Newcastle Disease Treatment Market by Type
2.1 Introduction
2.1.1 Live Attenuated Vaccine
2.1.2 Inactivated Vaccine
2.1.3 Conjugated Vaccine
2.2 Global Newcastle Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Newcastle Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Newcastle Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Newcastle Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Newcastle Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Newcastle Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Newcastle Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Newcastle Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Newcastle Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals
3.1.2 Veterinary Clinics
3.1.3 Veterinary Research Institutes
3.1.4 Retail Pharmacies
3.1.5 Others
3.2 Global Newcastle Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Newcastle Disease Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Newcastle Disease Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Newcastle Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Newcastle Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Newcastle Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Newcastle Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Newcastle Disease Treatment Revenue Breakdown by Application (2018-2029)
4 Newcastle Disease Treatment Competition Analysis by Players
4.1 Global Newcastle Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newcastle Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Newcastle Disease Treatment Market
4.4 Global Top Players Newcastle Disease Treatment Headquarters and Area Served
4.5 Key Players Newcastle Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Newcastle Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Indovax
5.1.1 Indovax Profile
5.1.2 Indovax Main Business
5.1.3 Indovax Newcastle Disease Treatment Products, Services and Solutions
5.1.4 Indovax Newcastle Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Indovax Recent Developments
5.2 Zoetis
5.2.1 Zoetis Profile
5.2.2 Zoetis Main Business
5.2.3 Zoetis Newcastle Disease Treatment Products, Services and Solutions
5.2.4 Zoetis Newcastle Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Zoetis Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Newcastle Disease Treatment Products, Services and Solutions
5.3.4 Eli Lilly Newcastle Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Newcastle Disease Treatment Products, Services and Solutions
5.4.4 Merck Newcastle Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Ceva
5.5.1 Ceva Profile
5.5.2 Ceva Main Business
5.5.3 Ceva Newcastle Disease Treatment Products, Services and Solutions
5.5.4 Ceva Newcastle Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Ceva Recent Developments
6 North America
6.1 North America Newcastle Disease Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Newcastle Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Newcastle Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Newcastle Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Newcastle Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Newcastle Disease Treatment Market Dynamics
11.1 Newcastle Disease Treatment Industry Trends
11.2 Newcastle Disease Treatment Market Drivers
11.3 Newcastle Disease Treatment Market Challenges
11.4 Newcastle Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
